Post-COVID Condition in Patients With Cardiovascular Disease: Are Antivirals the Answer?

JACC Adv. 2024 Jun 26;3(6):100962. doi: 10.1016/j.jacadv.2024.100962. eCollection 2024 Jun.

Authors

Maciej Dębski¹, Vasiliki Tsampasian¹, Vassilios S Vassiliou¹

Affiliation

¹ Norwich Medical School, University of East Anglia, Norwich, United Kingdom.

No abstract available

Keywords: cardiovascular disease; healthcare utilization; long covid; nirmatrelvir-ritonavir; post-acute sequelae of SARS-CoV-2 infection.

Publication types

Editorial